At the news
? BULLISHIMPACT 6/10 8-K filed Nov 9, 2026 at 16:50 ET
Novanta reported Q3 2026 revenue of $305M (+23.1% YoY, +9.9% organic) and adjusted EPS of $1.05 (+20.7% YoY), both above consensus estimates of $301M and $0.97. The company raised full-year 2026 revenue guidance to $1,135M-$1,140M and adjusted EPS to $3.66-$3.71, reflecting strong momentum from the Riverpoint Medical acquisition and organic growth.
- Q3 2026 GAAP revenue $305M, up 23.1% YoY; organic revenue growth 9.9%
- Adjusted diluted EPS $1.05, up 20.7% YoY vs consensus $0.97 (beat)
- Adjusted EBITDA $80.3M, up 38.3% YoY; margin expanded 290 bps to 26.3%
- Customer bookings increased 29% YoY; backlog grew to $543M
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access